For citations:
Nasonov E.L. NEW POSSIBILITIES OF PHARMACOTHERAPY FOR IMMUNOINFLAMMATORY RHEUMATIC DISEASES: A FOCUS ON INHIBITORS OF INTERLEUKIN-17. Rheumatology Science and Practice. 2017;55(1):68-86. https://doi.org/10.14412/1995-4484-2017-68-86
Nasonov E.L. NEW POSSIBILITIES OF PHARMACOTHERAPY FOR IMMUNOINFLAMMATORY RHEUMATIC DISEASES: A FOCUS ON INHIBITORS OF INTERLEUKIN-17. Rheumatology Science and Practice. 2017;55(1):68-86. https://doi.org/10.14412/1995-4484-2017-68-86